SIRT6 promotes tumorigenesis by activating oncogenic pathways such as Notch signaling, while also inhibiting necroptosis-mediated immune responses through repression of RIPK3, thereby enabling tumor immune evasion [69] (Figure 4 and Table 1). The gene discussed is SIRT6; the disease is neoplasm.